Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Earlier observational studies also found links between GLP-1 treatment and lower risks of alcohol and cannabis use disorders, opioid overdose, and alcohol-related hospitalization
Research observations have focused on receptor signaling and related biochemical markers, not on human-use applications
Golan R, Weissenberg R, Lewin LM
In September 2024, Hikma Pharmaceuticals PLC finalized the acquisition of Xellia Pharmaceuticals US finished dosage form business with a deal including a facility in Ohio, Sales and marketing capabilities, and an R&D center in Croatia, aiming to strengthen the commercial portfolio and production supplements
